
Sigcap Pharmaceuticals (I) Private Limited
This company manufactures and supplies pharmaceutical and chemical medical products for human and animal healthcare.
This company manufactures and supplies pharmaceutical and chemical medical products for human and animal healthcare.
Kolkata, West Bengal, India
+91-XXXXXXXXXX
U24232WB2007PTC120042
120042
Private Limited Indian Non-Government Company
25 Oct 2007
30 Sep 2023
31 Mar 2023
Unlisted
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Seema Jain ![]() | Director | 30-Aug-2022 | Current |
Rahul Todi ![]() | Director | 25-Oct-2007 | Current |
Sigcap Pharmaceuticals (I) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.07% increase. The company also saw a substantial fall in profitability, with a 264.78% decrease in profit. The company's net worth dipped by a decrease of 3.43%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Sigcap Pharmaceuticals (I) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Rahul Todi is a mutual person
Seema Jain is a mutual person
Seema Jain is a mutual person
Seema Jain is a mutual person
Seema Jain is a mutual person
Rahul Todi is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sigcap Pharmaceuticals (I), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sigcap Pharmaceuticals (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sigcap Pharmaceuticals (I)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sigcap Pharmaceuticals (I) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Sigcap Pharmaceuticals (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata.
Seema Jain was appointed as a Director was appointed as a Director on 30 Aug 2022 & has been associated with this company since 2 years 7 months .
Rahul Todi was appointed as a Director was appointed as a Director on 25 Oct 2007 & has been associated with this company since 17 years 6 months .
Sigcap Pharmaceuticals (I) Private Limited was registered on 25 Oct 2007 with Roc Kolkata & aged 17 years 6 months as per MCA records.
Sigcap Pharmaceuticals (I) Private Limited was incorporated on 25 Oct 2007.
The authorized share capital of Sigcap Pharmaceuticals (I) Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 7.88 M.
Currently 2 directors are associated with Sigcap Pharmaceuticals (I) Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sigcap Pharmaceuticals (I) Private Limited is 686 Anandapur 7Th Floor E.M. Bypass R.B. Connector Junction, India, Kolkata, West Bengal, 700107.
The corporate identification number (CIN) of Sigcap Pharmaceuticals (I) Private Limited is U24232WB2007PTC120042 and the company number is 120042 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Sigcap Pharmaceuticals (I) Private Limited has risen by 15.07%.
The financial reports for the fiscal year 2020 indicates that The net worth of Sigcap Pharmaceuticals (I) Private Limited has experienced an downturn of -3.43%.
The most recent Balance Sheet for Sigcap Pharmaceuticals (I) Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
TC
SS
GA
BR
AS